What is the official website of Eurofins BioPharma Product Testing India ?

The official website of Eurofins BioPharma Product Testing India is https://www.advinus.com/services/gmp-analytical-testing/.

What is Eurofins BioPharma Product Testing India 's cybersecurity risk score?

Eurofins BioPharma Product Testing India has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Eurofins BioPharma Product Testing India experienced?

According to Rankiteo, Eurofins BioPharma Product Testing India currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Eurofins BioPharma Product Testing India been affected by any supply chain cyber incidents ?

According to Rankiteo, Eurofins BioPharma Product Testing India has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Eurofins BioPharma Product Testing India have SOC 2 Type 1 certification ?

According to Rankiteo, Eurofins BioPharma Product Testing India is not certified under SOC 2 Type 1.

Does Eurofins BioPharma Product Testing India have SOC 2 Type 2 certification ?

According to Rankiteo, Eurofins BioPharma Product Testing India does not hold a SOC 2 Type 2 certification.

Does Eurofins BioPharma Product Testing India comply with GDPR ?

According to Rankiteo, Eurofins BioPharma Product Testing India is not listed as GDPR compliant.

Does Eurofins BioPharma Product Testing India have PCI DSS certification ?

According to Rankiteo, Eurofins BioPharma Product Testing India does not currently maintain PCI DSS compliance.

Does Eurofins BioPharma Product Testing India comply with HIPAA ?

According to Rankiteo, Eurofins BioPharma Product Testing India is not compliant with HIPAA regulations.

Does Eurofins BioPharma Product Testing India have ISO 27001 certification ?

According to Rankiteo,Eurofins BioPharma Product Testing India is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Eurofins BioPharma Product Testing India operate in ?

Eurofins BioPharma Product Testing India operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Eurofins BioPharma Product Testing India have ?

Eurofins BioPharma Product Testing India employs approximately 0 people worldwide.

Does Eurofins BioPharma Product Testing India own any subsidiaries ?

Eurofins BioPharma Product Testing India presently has no subsidiaries across any sectors.

How many LinkedIn followers does Eurofins BioPharma Product Testing India have ?

Eurofins BioPharma Product Testing India 's official LinkedIn profile has approximately 2,534 followers.

What is the NAICS classification code for Eurofins BioPharma Product Testing India ?

Eurofins BioPharma Product Testing India is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Eurofins BioPharma Product Testing India have a Crunchbase profile ?

No, Eurofins BioPharma Product Testing India does not have a profile on Crunchbase.

Does Eurofins BioPharma Product Testing India have a LinkedIn profile ?

Yes, Eurofins BioPharma Product Testing India maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/eurofins-biopharma-product-testing-india.

How many cybersecurity incidents has Eurofins BioPharma Product Testing India experienced ?

As of July 5, 2026, Rankiteo reports that Eurofins BioPharma Product Testing India has not experienced any cybersecurity incidents.

How many peer or competitor companies does Eurofins BioPharma Product Testing India have ?

Eurofins BioPharma Product Testing India has an estimated 5,700 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

EBPTI

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Eurofins BioPharma Product Testing India Vendor Cyber Rating & Cyber Score

advinus.com

Add Your Compliance Badge

Eurofins Biopharma Product Testing India Pvt Ltd, a US FDA inspected lab with NAI (“ZERO” 483) offers GMP testing of drug substance, drug products, intermediates, starting materials and raw materials for Pharmaceutical, Chemical and Food Industries. The state-of-the-art testing facility is located in Bangalore, India. All instruments in the laboratory are 21 CFR Part 11 compliant.

EBPTI A.I CyberSecurity Scoring

Scoring History

EBPTI

Eurofins BioPharma Product Testing India CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

EBPTI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for EBPTI

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eurofins BioPharma Product Testing India in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eurofins BioPharma Product Testing India in 2026.

Incident Types EBPTI vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eurofins BioPharma Product Testing India in 2026.

Incident History - EBPTI (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Eurofins BioPharma Product Testing India Subsidiaries

EBPTI

Pharmaceutical Manufacturing

Website: https://www.advinus.com/services/gmp-analytical-testing/

Company Size: 0

EurofinsBiotechnology Research

Eurofins Lancaster LaboratoriesBiotechnology Research

Eurofins PSS Insourcing SolutionsBiotechnology Research

Eurofins BioPharma Product Testing ItalyPharmaceutical Manufacturing

Eurofins IT Delivery CenterIT Services and IT Consulting

Eurofins Agroscience ServicesResearch

Eurofins Agroscience Biological SolutionsResearch

Eurofins Agroscience Seed ServicesResearch Services

Eurofins Agroscience Regulatory ConsultancyResearch Services

Eurofins Agroscience Biological AssessmentResearch Services

Eurofins Agroscience Consumer/Human SafetyResearch Services

Eurofins Agroscience Environmental SafetyResearch

Eurofins Agroscience Product ChemistryResearch Services

Eurofins do Brasil Análises de Alimentos e AmbientaisResearch Services

Eurofins Environment Testing (USA)Environmental Services

Eurofins GenomicsBiotechnology Research

Eurofins Food AssuranceProfessional Services

Eurofins BiomnisMedical and Diagnostic Laboratories

Eurofins Environment Testing FranceBiotechnology

Eurofins | Solutions DurablesServices de conseil en environnement

Eurofins Hygiène HospitalièreRecherche en biotechnologie

Eurofins Biopharma Product Testing (France)Pharmaceutical Manufacturing

Eurofins Analyses Alimentaires FranceBiotechnology Research

Eurofins Central LaboratoryBiotechnology Research

Eurofins DiscoveryBiotechnology

Eurofins CDMOPharmaceutical Manufacturing

Eurofins CDMO AlphoraPharmaceutical Manufacturing

Eurofins US Food, Feed, & Supplement TestingBiotechnology Research

Eurofins Danmark - LaboratoriumBiotechnology Research

Eurofins Product Testing Denmark A/SSecurity and Investigations

Eurofins Steins LaboratoriumBiotechnology Research

Eurofins Clinical DiagnosticsBiotechnology

Eurofins Clinical Trial SolutionsBiotechnology Research

Eurofins Food, Feed & Water BeneluxBiotechnology Research

Eurofins ChileFood and Beverage Services

Eurofins Agro & HortiResearch Services

Eurofins DiscoverXBiotechnology Research

Eurofins Genomics AmericasBiotechnology

Eurofins CanadaBiotechnology Research

Eurofins Environment BeneluxEnvironmental Services

DiatherixBiotechnology Research

Eurofins ViracorMedical and Diagnostic Laboratories

ExPeCT™ anti-CD19 (FMC63) CAR TMedical and Diagnostic Laboratories

Eurofins Viracor CMV TestingBiotechnology Research

TTViWATCH™ - Torque Teno Virus qPCRMedical and Diagnostic Laboratories

Eurofins AdvinusResearch Services

Eurofins Discovery Services IndiaResearch

Eurofins CDMO IndiaResearch Services

Eurofins Bioanalytical Services IndiaResearch Services

Eurofins Advinus Agrosciences IndiaResearch Services

Loading…

Eurofins BioPharma Product Testing India Similar Companies

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Loading…

NEWS

Eurofins BioPharma Product Testing India CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-14683

SUMMARY

A vulnerability was detected in HdrHistogram up to 2.2.2. Affected by this issue is the function org.HdrHistogram.AbstractHistogram.decodeFromCompressedByteBuffer of the file src/main/java/org/HdrHistogram/AbstractHistogram.java. The manipulation of the argument lengthOfCompressedContents results in uncontrolled memory allocation. The attack needs to be approached locally. The exploit is now public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 3.3)

cvss2

Base Score: 1.7

Complexity: LOW

AV:L/AC:L/Au:S/C:N/I:N/A:P

cvss3

Base Score: 3.3

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 1.9

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.8

REFERENCES

CVE-2026-14660

SUMMARY

A vulnerability was found in code-projects Online Job Portal 1.0. The affected element is an unknown function of the file login.php. Performing a manipulation of the argument txtUser/txtPass results in sql injection. The attack may be initiated remotely. The exploit has been made public and could be used.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-14659

SUMMARY

A vulnerability has been found in itsourcecode Hospital Management System 1.0. Impacted is an unknown function of the file /patientappointment.php. Such manipulation of the argument patiente leads to sql injection. The attack can be launched remotely. The exploit has been disclosed to the public and may be used.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-14658

SUMMARY

A vulnerability was detected in code-projects Assessment Management 1.0. This vulnerability affects unknown code of the file /lecturer/marking-scheme.php. The manipulation of the argument smarksrange[] results in sql injection. It is possible to launch the attack remotely. The exploit is now public and may be used.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-14657

SUMMARY

A flaw has been found in code-projects Assessment Management 1.0. This issue affects some unknown processing of the file /lecturer/marking-scheme.php of the component Database Query Handler. This manipulation of the argument squestions[] causes sql injection. The attack can be initiated remotely. The exploit has been published and may be used.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…